Unknown

Dataset Information

0

Detection and characterization of a clinical Escherichia coli ST3204 strain coproducing NDM-16 and MCR-1.


ABSTRACT: Objectives:A plasmid-mediated colistin resistance gene, mcr-1, has been reported worldwide and has caused concern regarding a major therapeutic challenge. Alarmingly, mcr-1 has spread into clinical carbapenem-resistant Enterobacteriaceae isolates, resulting in extensively drug-resistant and even pan drug-resistant isolates that can cause untreatable infections. In this study, we report isolation of an extensively drug-resistant Escherichia coli strain EC1188 that coproduces NDM-16 and MCR-1 from a urine sample taken from a patient with craniocerebral injury. Materials and methods:E. coli strain EC1188 was identified and subjected to genotyping, susceptibility testing and conjugation experiments. The genetic locations of blaNDM-16 and mcr-1 were established with southern blot hybridization. The complete genome sequence of this strain was obtained and the genetic characteristics of the mcr-1- and blaNDM-16-harboring plasmids were analyzed. In addition, comparative genetic analyses of mcr-1 and blaNDM-16 with closely related plasmids were also carried out. Results:Whole-genome sequencing revealed that strain EC1188 possess various resistance genes and virulence genes. S1-pulsed-field gel electrophoresis and southern blot suggested that the blaNDM-16 and mcr-1 genes were located on an ~65 kb plasmid and an ~80 kb plasmid, respectively. Moreover, the two genes could successfully transfer their resistance phenotype to E. coli strain C600. Sequence analysis showed that these two plasmids possessed high sequence similarity to previously reported blaNDM-5-harboring and mcr-1-harboring plasmids in China. Conclusion:To the best of our knowledge, this is the first report to isolate an E. coli strain that coproduces NDM-16 and MCR-1. In addition, we characterized the blaNDM-16-harboring plasmid for the first time. Our study further emphasizes that the co-occurrence of the two prevalent transferrable resistance plasmids in a single isolate is highly significant because infections caused by MCR-1-producing carbapenem-resistant Enterobacteriaceae isolates are increasing each year. It is imperative to perform active surveillance to prevent further dissemination of MCR-1-producing CRE isolates.

SUBMITTER: Li X 

PROVIDER: S-EPMC6101002 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Detection and characterization of a clinical <i>Escherichia coli</i> ST3204 strain coproducing NDM-16 and MCR-1.

Li Xi X   Mu Xinli X   Zhang Ping P   Zhao Dongdong D   Ji Jingshu J   Quan Jingjing J   Zhu Yongze Y   Yu Yunsong Y  

Infection and drug resistance 20180815


<h4>Objectives</h4>A plasmid-mediated colistin resistance gene, <i>mcr-1</i>, has been reported worldwide and has caused concern regarding a major therapeutic challenge. Alarmingly, <i>mcr-1</i> has spread into clinical carbapenem-resistant Enterobacteriaceae isolates, resulting in extensively drug-resistant and even pan drug-resistant isolates that can cause untreatable infections. In this study, we report isolation of an extensively drug-resistant <i>Escherichia coli</i> strain EC1188 that cop  ...[more]

Similar Datasets

| S-EPMC9449459 | biostudies-literature
| S-EPMC3677923 | biostudies-literature
| S-EPMC5826114 | biostudies-literature
| S-EPMC5738369 | biostudies-literature
| S-EPMC6834847 | biostudies-literature
| S-EPMC9241874 | biostudies-literature
| S-EPMC6559143 | biostudies-literature
| S-EPMC6662510 | biostudies-literature
| S-EPMC9241605 | biostudies-literature
| S-EPMC5192131 | biostudies-literature